1. Home
  2. PODD vs STE Comparison

PODD vs STE Comparison

Compare PODD & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • STE
  • Stock Information
  • Founded
  • PODD 2000
  • STE 1985
  • Country
  • PODD United States
  • STE United States
  • Employees
  • PODD N/A
  • STE N/A
  • Industry
  • PODD Medical/Dental Instruments
  • STE Industrial Specialties
  • Sector
  • PODD Health Care
  • STE Health Care
  • Exchange
  • PODD Nasdaq
  • STE Nasdaq
  • Market Cap
  • PODD 23.8B
  • STE 23.0B
  • IPO Year
  • PODD 2007
  • STE 1992
  • Fundamental
  • Price
  • PODD $340.29
  • STE $247.81
  • Analyst Decision
  • PODD Strong Buy
  • STE Buy
  • Analyst Count
  • PODD 18
  • STE 9
  • Target Price
  • PODD $334.50
  • STE $268.25
  • AVG Volume (30 Days)
  • PODD 532.2K
  • STE 486.0K
  • Earning Date
  • PODD 11-06-2025
  • STE 11-05-2025
  • Dividend Yield
  • PODD N/A
  • STE 0.92%
  • EPS Growth
  • PODD N/A
  • STE 61.94
  • EPS
  • PODD 3.32
  • STE 6.53
  • Revenue
  • PODD $2,359,500,000.00
  • STE $5,571,115,000.00
  • Revenue This Year
  • PODD $29.18
  • STE $9.24
  • Revenue Next Year
  • PODD $18.09
  • STE $6.05
  • P/E Ratio
  • PODD $102.63
  • STE $37.94
  • Revenue Growth
  • PODD 26.00
  • STE 6.42
  • 52 Week Low
  • PODD $225.37
  • STE $200.98
  • 52 Week High
  • PODD $353.50
  • STE $253.00
  • Technical
  • Relative Strength Index (RSI)
  • PODD 59.53
  • STE 55.00
  • Support Level
  • PODD $336.00
  • STE $243.01
  • Resistance Level
  • PODD $351.94
  • STE $253.00
  • Average True Range (ATR)
  • PODD 8.16
  • STE 4.19
  • MACD
  • PODD -1.50
  • STE -0.19
  • Stochastic Oscillator
  • PODD 46.37
  • STE 61.80

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Share on Social Networks: